Arrowhead Pharmaceuticals (ARWR) Q2 2021 Earnings Report
MX:ARWR Q2 2021 EPS Results
- Actual EPS
- -MXN 4.88
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 3.76
MX:ARWR Q2 2021 Revenue Results
- Actual Revenue
- MXN 616.39M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +39.45%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 05/04/2021
- Time
- After Close
- Conference Call
- Tuesday, May 4, 2021
MX:ARWR Upcoming Earnings
Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ARWR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 30, 2026 | 2026 (Q4) | -28.52- | -2.07 | ― | ― |
| Aug 04, 2026 | 2026 (Q3) | -23.99-25.55 | -23.67 | -7.94% (-1.88) | |
| May 07, 2026 | 2026 (Q2) | -20.57-17.47 | 51.66 | -133.82% (-69.13) | |
| Feb 05, 2026 | 2026 (Q1) | 0.704.13 | -26.11 | 115.83% (+30.25) | |
| Nov 25, 2025 | 2025 (Q4) | -2.10-2.07 | -25.55 | 91.91% (+23.48) | |
| Aug 07, 2025 | 2025 (Q3) | -17.88-23.67 | -25.92 | 8.70% (+2.25) | |
| May 12, 2025 | 2025 (Q2) | -3.5151.66 | -19.16 | 369.61% (+70.82) | |
| Feb 10, 2025 | 2025 (Q1) | -8.94-26.11 | -23.29 | -12.10% (-2.82) | |
| Nov 26, 2024 | 2024 (Q4) | -21.04-25.55 | -19.16 | -33.33% (-6.39) | |
| Aug 08, 2024 | 2024 (Q3) | -9.94-25.92 | -18.03 | -43.75% (-7.89) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed